Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT04270708
Eligibility Criteria:
Inclusion Criteria:
1. Children aged 4-18 yrs referred for an EEG under sedation..
2. A Neurologist derived diagnosis of Autistic Spectrum Disorder (ASD).
3. ASA 1 or 2
Exclusion Criteria:
1. Allergy to study drug
2. Congenital heart disease, bradycardia \< 60 or know arrhythmia/AV block.
3. Vasoactive drugs or treatment for arterial HTN.
4. Known Renal dysfunction Creatinine Clearance \< 30% or known Liver dysfunction (Elevated LFT's).
5. Concurrent Treatment with drugs know to interact with Dexmedetomidine:
1. Atipical Antipsychotics / Phenothiazines
2. Tricyclic anti-depressents
3. Lacosamide treatment - Antiepileptic.
4. PDE V inhibitors (Viagra)
5. Beta-blockers
6. Phenothiazines
7. First generation Anti-histamines
6. Significant rhinorrhea.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
19 Years
Study:
NCT04270708
Study Brief:
Protocol Section:
NCT04270708